54 related articles for article (PubMed ID: 19767764)
1. Metabolic map of osthole and its effect on lipids.
Zhao Q; Li XM; Liu HN; Gonzalez FJ; Li F
Xenobiotica; 2018 Mar; 48(3):285-299. PubMed ID: 28287022
[TBL] [Abstract][Full Text] [Related]
2. Charged Tags for the Identification of Oxidative Drug Metabolites Based on Electrochemistry and Mass Spectrometry.
Gutmann A; Wesenberg LJ; Peez N; Waldvogel SR; Hoffmann T
ChemistryOpen; 2020 May; 9(5):568-572. PubMed ID: 32382470
[TBL] [Abstract][Full Text] [Related]
3. A metabolomic perspective of pazopanib-induced acute hepatotoxicity in mice.
Wang YK; Yang XN; Liang WQ; Xiao Y; Zhao Q; Xiao XR; Gonzalez FJ; Li F
Xenobiotica; 2019 Jun; 49(6):655-670. PubMed ID: 29897827
[TBL] [Abstract][Full Text] [Related]
4. Transcript abundance of hepatic drug-metabolizing enzymes in two dog breeds compared with 14 species including humans.
Uno Y; Yamato O; Yamazaki H
Drug Metab Pharmacokinet; 2024 Apr; 55():101002. PubMed ID: 38452615
[TBL] [Abstract][Full Text] [Related]
5. Differences in xanthotoxin metabolites in seven mammalian liver microsomes.
Liu W; Zhi D; Wang L; Yang A; Zhang L; Ahiasi-Mensah J; He X
Exp Ther Med; 2020 Oct; 20(4):3846-3852. PubMed ID: 32855735
[TBL] [Abstract][Full Text] [Related]
6. Mechanistic insights into dimethyl cardamonin-mediated pharmacological effects: A double control of the AMPK-HMGB1 signaling axis.
Bailly C; Vergoten G
Life Sci; 2020 Dec; 263():118601. PubMed ID: 33086122
[TBL] [Abstract][Full Text] [Related]
7. Characterization of cardamonin metabolism by P450 in different species via HPLC-ESI-ion trap and UPLC-ESI-quadrupole mass spectrometry.
He YQ; Yang L; Liu Y; Zhang JW; Tang J; Su J; Li YY; Lu YL; Wang CH; Yang L; Wang ZT
Acta Pharmacol Sin; 2009 Oct; 30(10):1462-70. PubMed ID: 19767764
[TBL] [Abstract][Full Text] [Related]
8. Kinetic characteristics of norcocaine N-hydroxylation in mouse and human liver microsomes: involvement of CYP enzymes.
Pellinen P; Kulmala L; Konttila J; Auriola S; Pasanen M; Juvonen R
Arch Toxicol; 2000 Nov; 74(9):511-20. PubMed ID: 11131030
[TBL] [Abstract][Full Text] [Related]
9. Characterization of nuciferine metabolism by P450 enzymes and uridine diphosphate glucuronosyltransferases in liver microsomes from humans and animals.
LU YL; HE YQ; WANG M; ZHANG L; YANG L; WANG ZT; JI G
Acta Pharmacol Sin; 2010 Dec; 31(12):1635-42. PubMed ID: 21127497
[TBL] [Abstract][Full Text] [Related]
10. Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes.
Eagling VA; Tjia JF; Back DJ
Br J Clin Pharmacol; 1998 Feb; 45(2):107-14. PubMed ID: 9491822
[TBL] [Abstract][Full Text] [Related]
11. Evidence for the involvement of human liver microsomes CYP1A2 in the mono-hydroxylation of daidzein.
Peng WX; Wang LS; Li HD; Abd El-Aty AM; Chen GL; Zhou HH
Clin Chim Acta; 2003 Aug; 334(1-2):77-85. PubMed ID: 12867277
[TBL] [Abstract][Full Text] [Related]
12. Interspecies metabolic diversity of harmaline and harmine in in vitro 11 mammalian liver microsomes.
Li S; Teng L; Liu W; Cheng X; Jiang B; Wang Z; Wang C
Drug Test Anal; 2017 May; 9(5):754-768. PubMed ID: 27377954
[TBL] [Abstract][Full Text] [Related]
13. Cytochrome P450 and the biological clock in mammals.
Froy O
Curr Drug Metab; 2009 Feb; 10(2):104-15. PubMed ID: 19275546
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
